We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.91B
1-Year Est. Return 31.61%
This Fund
S&P 500
This Quarter Est. Return
+15.65%
1 Year Est. Return
+31.61%
3 Year Est. Return
+70.8%
5 Year Est. Return
+92.39%
10 Year Est. Return
+369.61%
AUM
$1.91B
AUM Growth
+$137M
Cap. Flow
-$16.4M
Cap. Flow %
-0.86%
Top 10 Hldgs %
40.05%
Holding
222
New
13
Increased
53
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$15.5M
2
AOS icon
A.O. Smith
AOS
+$7.29M
3
PAYX icon
Paychex
PAYX
+$2.93M
4
DVN icon
Devon Energy
DVN
+$2.28M
5
LW icon
Lamb Weston
LW
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 31.5%
2 Industrials 20.48%
3 Healthcare 13.63%
4 Financials 8.33%
5 Materials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSP icon
101
Invesco S&P 500 Equal Weight ETF
RSP
$98.8B
$1.25M 0.07%
5,866
+175
+3% +$35.8K
PM icon
102
Philip Morris
PM
$304B
$1.24M 0.07%
6,865
IVW icon
103
iShares S&P 500 Growth ETF
IVW
$76.1B
$1.16M 0.06%
8,430
-3
-0% -$396
V icon
104
Visa
V
$701B
$1.16M 0.06%
3,378
+28
+0.8% +$8.99K
PFE icon
105
Pfizer
PFE
$158B
$1.15M 0.06%
47,721
-1,325
-3% -$34.7K
CSCO icon
106
Cisco
CSCO
$434B
$1.14M 0.06%
9,742
ETN icon
107
Eaton
ETN
$165B
$1.12M 0.06%
2,631
-175
-6% -$70.6K
UNP icon
108
Union Pacific
UNP
$169B
$1.12M 0.06%
4,103
LRCX icon
109
Lam Research
LRCX
$342B
$1.09M 0.06%
2,518
-132
-5% -$40.1K
BMRN icon
110
BioMarin Pharmaceuticals
BMRN
$12.7B
$1.04M 0.05%
18,243
+382
+2% +$20.9K
GMAB icon
111
Genmab
GMAB
$20.1B
$1.03M 0.05%
37,633
+470
+1% +$12.5K
TSLA icon
112
Tesla
TSLA
$1.42T
$1.03M 0.05%
2,445
-159
-6% -$63.2K
ZBH icon
113
Zimmer Biomet
ZBH
$17.8B
$993K 0.05%
11,539
-7,025
-38% -$616K
VPL icon
114
Vanguard FTSE Pacific ETF
VPL
$8.59B
$965K 0.05%
8,340
+85
+1% +$9.4K
ALNY icon
115
Alnylam Pharmaceuticals
ALNY
$33.5B
$965K 0.05%
3,204
+123
+4% +$37.1K
MCD icon
116
McDonald's
MCD
$182B
$931K 0.05%
3,444
+27
+0.8% +$7.74K
ORCL icon
117
Oracle
ORCL
$417B
$928K 0.05%
6,330
-2,288
-27% -$415K
DE icon
118
Deere & Co
DE
$182B
$913K 0.05%
1,439
VEA icon
119
Vanguard FTSE Developed Markets ETF
VEA
$234B
$885K 0.05%
12,423
+981
+9% +$68.3K
EFA icon
120
iShares MSCI EAFE ETF
EFA
$78.2B
$868K 0.05%
8,355
+2,400
+40% +$247K
VWO icon
121
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$867K 0.05%
14,516
+1,114
+8% +$65.5K
VO icon
122
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$866K 0.05%
10,747
+3
+0% +$233
FCX icon
123
Freeport-McMoran
FCX
$99.6B
$850K 0.04%
13,519
NTLA icon
124
Intellia Therapeutics
NTLA
$1.66B
$841K 0.04%
49,680
+1,250
+3% +$17.5K
GLD icon
125
SPDR Gold Trust
GLD
$145B
$830K 0.04%
2,254

Similar funds

Grandfield & Dodd's Q2 2026 Portfolio in Review

As of Q2 2026, Grandfield & Dodd held 222 positions worth $1.91B, up 7.7% from $1.77B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grandfield & Dodd's Q2 2026 filing shows 13 new, 53 increased, 83 reduced and 5 closed positions. Its largest new stake was Honeywell Aerospace: 3,390 shares worth $750K. The largest sale was Applied Materials, an estimated $9.37M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Grandfield & Dodd's largest Q2 2026 buy was Honeywell Aerospace: 3,390 shares worth $750K.
  • Grandfield & Dodd added most to Boeing in Q2 2026, an estimated $15.5M increase.
  • Grandfield & Dodd's biggest Q2 2026 reduction was Applied Materials, cutting an estimated $9.37M.
  • Grandfield & Dodd fully exited Coterra Energy in Q2 2026, selling an estimated $1.76M.
  • Grandfield & Dodd's ten largest holdings make up 40% of its $1.91B portfolio in Q2 2026.
  • Grandfield & Dodd opened 13 new positions and closed 5 in Q2 2026.
  • Grandfield & Dodd's portfolio value rose 7.7% quarter-over-quarter to $1.91B.

Based on Grandfield & Dodd's 13F filing for Q2 2026, filed 7 Aug 2026.